The China-Japan Friendship Hospital also abbreviated as China-Japan Hospital was established through the cooperation of the Chinese and Japanese governments during the 1980s. The hospital has been directly affiliated with China's Ministry of Health since its first day of operation, October 23, 1984.

There are 1,500 beds in China-Japan Friendship Hospital.

During the past decade, China-Japan Friendship Hospital conducted 140 clinical trials. In the 10-year time frame, 140 clinical trials started and 12 clinical trials were completed, i.e. on average, 8.6% percent of trials that started reached the finish line to date. In the past 5 years, 76 clinical trials started and 9 clinical trials were completed. i.e. 11.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "China-Japan Friendship Hospital" #1 sponsor was "China-Japan Friendship Hospital" with 23 trials, followed by "Capital Medical University" with 8 trials sponsored, "Boehringer Ingelheim" with 6 trials sponsored, "Cancer Institute and Hospital, Chinese Academy of Medical Sciences" with 4 trials sponsored and "Jiangsu HengRui Medicine Co., Ltd." with 4 trials sponsored. Other sponsors include 121 different institutions and companies that sponsored additional 95 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "China-Japan Friendship Hospital" #1 collaborator was "China-Japan Friendship Hospital" with 22 trials as a collaborator, "LinkDoc Technology (Beijing) Co. Ltd." with 9 trials as a collaborator, "Peking University Cancer Hospital & Institute" with 7 trials as a collaborator, "Beijing Chao Yang Hospital" with 6 trials as a collaborator and "Cancer Institute and Hospital, Chinese Academy of Medical Sciences" with 5 trials as a collaborator. Other collaborators include 348 different institutions and companies that were collaborators in the rest 274 trials.

According to Clinical.Site data, the most researched conditions in "China-Japan Friendship Hospital" are "Non-small Cell Lung Cancer" (6 trials), "Asthma" (5 trials), "Influenza" (5 trials), "Lung Cancer" (5 trials) and "COPD Exacerbation" (4 trials). Many other conditions were trialed in "China-Japan Friendship Hospital" in a lesser frequency.

Most popular intervention types in "China-Japan Friendship Hospital" are "Drug" (93 trials), "Procedure" (27 trials), "Other" (19 trials), "Device" (16 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (33 trials), "Surgeries" (7 trials), "placebo" (5 trials), "Anlotinib" (3 trials) and "IBI362" (3 trials). Other intervention names were less common.

The vast majority of trials in "China-Japan Friendship Hospital" are 163 trials for "All" genders and 8 trials for "Female" genders.

Currently, there are NaN active trials in "China-Japan Friendship Hospital". 8 are not yet recruiting, 46 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 56 completed trials in China-Japan Friendship Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in China-Japan Friendship Hospital, 9 "Phase 1" clinical trials were conducted, 28 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 16 trials, and there were also 33 trials that are defined as “Not Applicable".

China-Japan Friendship Hospital has several departments that took part in Clinical trials: "Center for Biomedical Imaging Research, Department of Biomedical Engineering, Tsinghua University" - 2 trials, "National Engineering Laboratory for Neuromodulation" - 2 trials